PSB INDUSTRIES (EPA:PSB) - Exclusive discussions for an injection molding acquisition in the Healthcare and Industry markets
Transparency directive : regulatory news
20/02/2015 14:11
Click here to download pdf version
Press Release
19th February 2015
Ambition 2020: Exclusive discussions for an injection molding acquisition
in the Healthcare and Industry markets
As part of its Ambition 2020 strategic plan, PSB INDUSTRIES announced that it is
into exclusive discussions for the acquisition of PLASTIBELL, subject to
conditions precedent. The group, with operations in France, Mexico, and Poland,
is owned by Michel Maradan (founder), FCDE (Fonds de Consolidation et de
Développement des Entreprises), and CM-CIC Investissement.
PLASTIBELL Group, an international player specialized in injection molding,
posted nearly EUR50 million in revenues in 2014. With its industrial facilities
in three countries (4 in France, 1 in Mexico, 1 in Poland) and its ISO7 clean
rooms in each country, PLASTIBELL has enjoyed strong growth in the Healthcare
market and has the capacity to serve leading Healthcare and Industry customers
in France and around the globe.
In line with the PSB INDUSTRIES Ambition 2020 strategic plan, the PLASTIBELL
Group acquisition would allow PSB INDUSTRIES to have a strong position on the
Healthcare market, supported by a history of success and expertise in high
value-added growth markets.
PSB INDUSTRIES is an innovation-driven industrial group with leadership
positions in packaging and specialty chemicals. The group reported consolidated
revenues of EUR262 million in 2014, including over 60% from international sales.
The group has production plants in France, the United States, Japan, and Mexico.